Related Experiment Video
Updated: Mar 6, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.5K
Challenges of Inpatient Glycemic Control
Sally O Gerard1, Josephine Ritchie
1Fairfield University School of Nursing, Fairfield, Connecticut (Dr Gerard); Professional Development Department, Stamford Hospital, Stamford, Connecticut (Dr Gerard); and Nursing Department, Western Connecticut Health Network, Danbury (Dr Ritchie).
Journal of Nursing Care Quality
|March 22, 2017
Summary
Hyperglycemia, or high blood sugar, affects over 30% of hospitalized patients and is linked to worse outcomes. This article reviews challenges and solutions for managing blood sugar in non-critical care settings.
Area of Science:
- Internal Medicine
- Endocrinology
- Hospital Management
Background:
- Hyperglycemia affects over 30% of hospitalized patients.
- This condition is associated with increased mortality and adverse patient outcomes.
- Current dysglycemia management systems often prioritize critical care areas.
Purpose of the Study:
- To provide an overview of the challenges in glycemic control within non-critical care hospital settings.
- To highlight strategies for improving blood sugar management outside of intensive care units.
Main Methods:
- Review of existing literature and clinical practices.
- Analysis of barriers to effective glycemic control in general hospital wards.
- Identification of successful intervention strategies.
Main Results:
- Non-critical care areas face unique challenges in managing hyperglycemia.
- Standardized order sets can streamline treatment protocols.
- Critical pathways improve care consistency.
- Professional education enhances staff competency.
- Collaborative systems foster multidisciplinary approaches.
Conclusions:
- Effective glycemic control in non-critical care requires tailored strategies.
- Implementation of standardized order sets, critical pathways, professional education, and collaborative systems can significantly improve blood sugar management.
- Addressing these challenges is crucial for reducing mortality and improving patient outcomes in general hospital populations.
More Related Videos
Related Concept Videos
01:15Hypoglycemia and Glucagon
1.1K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.1K
01:15Diabetes: Management and Pharmacotherapy
1.2K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.2K
01:22Diabetes Mellitus: Type 2 and Gestational
5.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.2K
01:16Insulin: Dosing Regimen and Adverse Effects
973
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
973
01:30Acute Pancreatitis II: Clinical Manifestations and Management
980
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
980
01:06Oral Hypoglycemic Agents: Glinides
776
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
776